Since the vast majority of PCa cells express high levels of androgen receptor (AR) (4), hormonal therapy (i.e. androgen ablation or AR inhibition) remains the mainstay of treatment for men diagnosed with recurrent or advanced disease (2). Here, AR is linked to posterior cortical atrophy.